nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP3A4—Fingolimod—multiple sclerosis	0.059	0.139	CbGbCtD
Primidone—CYP2C19—Prednisone—multiple sclerosis	0.0477	0.112	CbGbCtD
Primidone—CYP2B6—Dexamethasone—multiple sclerosis	0.0468	0.11	CbGbCtD
Primidone—CYP3A4—Methylprednisolone—multiple sclerosis	0.038	0.0896	CbGbCtD
Primidone—CYP2C8—Dexamethasone—multiple sclerosis	0.0355	0.0835	CbGbCtD
Primidone—CYP2C19—Dexamethasone—multiple sclerosis	0.0298	0.0701	CbGbCtD
Primidone—CYP3A4—Triamcinolone—multiple sclerosis	0.0288	0.0679	CbGbCtD
Primidone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0278	0.0653	CbGbCtD
Primidone—CYP2C9—Dexamethasone—multiple sclerosis	0.0247	0.0583	CbGbCtD
Primidone—CYP3A4—Betamethasone—multiple sclerosis	0.0247	0.0582	CbGbCtD
Primidone—CYP3A4—Prednisolone—multiple sclerosis	0.0244	0.0575	CbGbCtD
Primidone—CYP3A4—Prednisone—multiple sclerosis	0.0231	0.0543	CbGbCtD
Primidone—Anaemia megaloblastic—Azathioprine—multiple sclerosis	0.0165	0.0525	CcSEcCtD
Primidone—CYP3A4—Dexamethasone—multiple sclerosis	0.0144	0.0339	CbGbCtD
Primidone—Personality change—Prednisolone—multiple sclerosis	0.0135	0.0428	CcSEcCtD
Primidone—Personality change—Triamcinolone—multiple sclerosis	0.0124	0.0394	CcSEcCtD
Primidone—Personality change—Methylprednisolone—multiple sclerosis	0.0124	0.0393	CcSEcCtD
Primidone—Personality change—Dexamethasone—multiple sclerosis	0.0112	0.0357	CcSEcCtD
Primidone—Personality change—Betamethasone—multiple sclerosis	0.0112	0.0357	CcSEcCtD
Primidone—CHRNA4—peripheral nervous system—multiple sclerosis	0.0107	0.0533	CbGeAlD
Primidone—GRIK2—nerve—multiple sclerosis	0.0104	0.0517	CbGeAlD
Primidone—Personality change—Prednisone—multiple sclerosis	0.00979	0.0311	CcSEcCtD
Primidone—CHRNA4—nerve—multiple sclerosis	0.00837	0.0415	CbGeAlD
Primidone—Anaemia megaloblastic—Methotrexate—multiple sclerosis	0.00666	0.0212	CcSEcCtD
Primidone—Blood disorder—Cladribine—multiple sclerosis	0.00574	0.0182	CcSEcCtD
Primidone—GRIA2—brainstem—multiple sclerosis	0.00495	0.0245	CbGeAlD
Primidone—GABRA6—brainstem—multiple sclerosis	0.00478	0.0237	CbGeAlD
Primidone—Depression—Fingolimod—multiple sclerosis	0.00471	0.015	CcSEcCtD
Primidone—GRIK2—brainstem—multiple sclerosis	0.00447	0.0222	CbGeAlD
Primidone—GRIK2—retina—multiple sclerosis	0.00431	0.0214	CbGeAlD
Primidone—Systemic lupus erythematosus—Triamcinolone—multiple sclerosis	0.00429	0.0136	CcSEcCtD
Primidone—Connective tissue disorder—Fingolimod—multiple sclerosis	0.00417	0.0132	CcSEcCtD
Primidone—Eye disorder—Fingolimod—multiple sclerosis	0.00397	0.0126	CcSEcCtD
Primidone—Mental disorder—Fingolimod—multiple sclerosis	0.00372	0.0118	CcSEcCtD
Primidone—CHRNA4—brainstem—multiple sclerosis	0.00359	0.0178	CbGeAlD
Primidone—GABRB2—brainstem—multiple sclerosis	0.00352	0.0175	CbGeAlD
Primidone—CHRNA7—retina—multiple sclerosis	0.00351	0.0174	CbGeAlD
Primidone—Suicidal ideation—Methylprednisolone—multiple sclerosis	0.00338	0.0107	CcSEcCtD
Primidone—Ataxia—Cladribine—multiple sclerosis	0.00327	0.0104	CcSEcCtD
Primidone—GABRA2—brainstem—multiple sclerosis	0.00322	0.016	CbGeAlD
Primidone—GRIA2—midbrain—multiple sclerosis	0.00315	0.0156	CbGeAlD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00312	0.00992	CcSEcCtD
Primidone—GRIK2—medulla oblongata—multiple sclerosis	0.00312	0.0155	CbGeAlD
Primidone—GABRA1—brainstem—multiple sclerosis	0.00311	0.0154	CbGeAlD
Primidone—GRIA2—spinal cord—multiple sclerosis	0.00308	0.0153	CbGeAlD
Primidone—Suicidal ideation—Dexamethasone—multiple sclerosis	0.00307	0.00976	CcSEcCtD
Primidone—Suicidal ideation—Betamethasone—multiple sclerosis	0.00307	0.00976	CcSEcCtD
Primidone—Nervous system disorder—Fingolimod—multiple sclerosis	0.00296	0.00939	CcSEcCtD
Primidone—Skin disorder—Fingolimod—multiple sclerosis	0.00293	0.0093	CcSEcCtD
Primidone—GRIK2—midbrain—multiple sclerosis	0.00285	0.0141	CbGeAlD
Primidone—GRIK2—spinal cord—multiple sclerosis	0.00278	0.0138	CbGeAlD
Primidone—Suicidal ideation—Prednisone—multiple sclerosis	0.00268	0.0085	CcSEcCtD
Primidone—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.0026	0.00827	CcSEcCtD
Primidone—Fatigue—Fingolimod—multiple sclerosis	0.0026	0.00826	CcSEcCtD
Primidone—GRIA2—nervous system—multiple sclerosis	0.00259	0.0129	CbGeAlD
Primidone—Eruption—Methotrexate—multiple sclerosis	0.00255	0.0081	CcSEcCtD
Primidone—GABRA6—nervous system—multiple sclerosis	0.00251	0.0124	CbGeAlD
Primidone—GRIA2—central nervous system—multiple sclerosis	0.0025	0.0124	CbGeAlD
Primidone—GABRG2—medulla oblongata—multiple sclerosis	0.00245	0.0122	CbGeAlD
Primidone—GABRB2—medulla oblongata—multiple sclerosis	0.00245	0.0122	CbGeAlD
Primidone—GRIA2—cerebellum—multiple sclerosis	0.00244	0.0121	CbGeAlD
Primidone—GABRA5—nervous system—multiple sclerosis	0.00243	0.0121	CbGeAlD
Primidone—GABRA6—central nervous system—multiple sclerosis	0.00241	0.012	CbGeAlD
Primidone—Connective tissue disorder—Cladribine—multiple sclerosis	0.00236	0.00751	CcSEcCtD
Primidone—CHRFAM7A—nervous system—multiple sclerosis	0.00236	0.0117	CbGeAlD
Primidone—GABRA6—cerebellum—multiple sclerosis	0.00236	0.0117	CbGeAlD
Primidone—GRIK2—nervous system—multiple sclerosis	0.00234	0.0116	CbGeAlD
Primidone—GABRA5—central nervous system—multiple sclerosis	0.00234	0.0116	CbGeAlD
Primidone—CHRNA4—midbrain—multiple sclerosis	0.00229	0.0114	CbGeAlD
Primidone—CHRFAM7A—central nervous system—multiple sclerosis	0.00227	0.0113	CbGeAlD
Primidone—GABRA3—nervous system—multiple sclerosis	0.00226	0.0112	CbGeAlD
Primidone—GRIK2—central nervous system—multiple sclerosis	0.00226	0.0112	CbGeAlD
Primidone—Eye disorder—Cladribine—multiple sclerosis	0.00225	0.00714	CcSEcCtD
Primidone—GABRB2—midbrain—multiple sclerosis	0.00224	0.0111	CbGeAlD
Primidone—GABRG2—midbrain—multiple sclerosis	0.00224	0.0111	CbGeAlD
Primidone—CHRNA4—spinal cord—multiple sclerosis	0.00223	0.0111	CbGeAlD
Primidone—GABRA4—nervous system—multiple sclerosis	0.0022	0.0109	CbGeAlD
Primidone—GRIK2—cerebellum—multiple sclerosis	0.0022	0.0109	CbGeAlD
Primidone—GABRB2—spinal cord—multiple sclerosis	0.00219	0.0109	CbGeAlD
Primidone—GABRG2—spinal cord—multiple sclerosis	0.00219	0.0109	CbGeAlD
Primidone—GABRA3—central nervous system—multiple sclerosis	0.00218	0.0108	CbGeAlD
Primidone—GABRA1—medulla oblongata—multiple sclerosis	0.00217	0.0107	CbGeAlD
Primidone—Asthenia—Fingolimod—multiple sclerosis	0.00216	0.00687	CcSEcCtD
Primidone—GABRA4—central nervous system—multiple sclerosis	0.00212	0.0105	CbGeAlD
Primidone—Mental disorder—Cladribine—multiple sclerosis	0.00211	0.0067	CcSEcCtD
Primidone—Malnutrition—Cladribine—multiple sclerosis	0.00209	0.00665	CcSEcCtD
Primidone—GABRA4—cerebellum—multiple sclerosis	0.00207	0.0103	CbGeAlD
Primidone—Agranulocytosis—Azathioprine—multiple sclerosis	0.00203	0.00646	CcSEcCtD
Primidone—Dizziness—Fingolimod—multiple sclerosis	0.00199	0.00633	CcSEcCtD
Primidone—GRIA2—brain—multiple sclerosis	0.00198	0.00983	CbGeAlD
Primidone—GABRA1—midbrain—multiple sclerosis	0.00198	0.00982	CbGeAlD
Primidone—Visual disturbance—Prednisolone—multiple sclerosis	0.00198	0.00629	CcSEcCtD
Primidone—Anaemia—Cladribine—multiple sclerosis	0.00194	0.00615	CcSEcCtD
Primidone—GABRA1—spinal cord—multiple sclerosis	0.00193	0.00959	CbGeAlD
Primidone—GABRA6—brain—multiple sclerosis	0.00191	0.0095	CbGeAlD
Primidone—CHRNA7—nervous system—multiple sclerosis	0.00191	0.00946	CbGeAlD
Primidone—Headache—Fingolimod—multiple sclerosis	0.00189	0.006	CcSEcCtD
Primidone—CHRNA4—nervous system—multiple sclerosis	0.00188	0.00934	CbGeAlD
Primidone—GABRA5—brain—multiple sclerosis	0.00186	0.00921	CbGeAlD
Primidone—GABRG2—nervous system—multiple sclerosis	0.00184	0.00915	CbGeAlD
Primidone—GABRB2—nervous system—multiple sclerosis	0.00184	0.00915	CbGeAlD
Primidone—CHRNA7—central nervous system—multiple sclerosis	0.00184	0.00911	CbGeAlD
Primidone—CHRNA4—central nervous system—multiple sclerosis	0.00181	0.00899	CbGeAlD
Primidone—CHRFAM7A—brain—multiple sclerosis	0.00181	0.00896	CbGeAlD
Primidone—GRIK2—brain—multiple sclerosis	0.00179	0.00888	CbGeAlD
Primidone—Arthralgia—Cladribine—multiple sclerosis	0.00178	0.00566	CcSEcCtD
Primidone—GABRB2—central nervous system—multiple sclerosis	0.00178	0.00881	CbGeAlD
Primidone—GABRG2—central nervous system—multiple sclerosis	0.00178	0.00881	CbGeAlD
Primidone—CHRNA4—cerebellum—multiple sclerosis	0.00177	0.00879	CbGeAlD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00177	0.00562	CcSEcCtD
Primidone—Drowsiness—Mitoxantrone—multiple sclerosis	0.00176	0.0056	CcSEcCtD
Primidone—GABRB2—cerebellum—multiple sclerosis	0.00174	0.00861	CbGeAlD
Primidone—GABRG2—cerebellum—multiple sclerosis	0.00174	0.00861	CbGeAlD
Primidone—GABRA3—brain—multiple sclerosis	0.00173	0.00858	CbGeAlD
Primidone—GABRA4—brain—multiple sclerosis	0.00169	0.00836	CbGeAlD
Primidone—GABRA2—nervous system—multiple sclerosis	0.00169	0.00836	CbGeAlD
Primidone—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.00168	0.00534	CcSEcCtD
Primidone—Nervous system disorder—Cladribine—multiple sclerosis	0.00168	0.00532	CcSEcCtD
Primidone—Skin disorder—Cladribine—multiple sclerosis	0.00166	0.00527	CcSEcCtD
Primidone—Visual disturbance—Dexamethasone—multiple sclerosis	0.00165	0.00525	CcSEcCtD
Primidone—Visual disturbance—Betamethasone—multiple sclerosis	0.00165	0.00525	CcSEcCtD
Primidone—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00164	0.00522	CcSEcCtD
Primidone—Anorexia—Cladribine—multiple sclerosis	0.00163	0.00518	CcSEcCtD
Primidone—GABRA1—nervous system—multiple sclerosis	0.00163	0.00808	CbGeAlD
Primidone—GABRA2—central nervous system—multiple sclerosis	0.00162	0.00805	CbGeAlD
Primidone—GABRA2—cerebellum—multiple sclerosis	0.00159	0.00786	CbGeAlD
Primidone—Anaemia—Azathioprine—multiple sclerosis	0.00157	0.005	CcSEcCtD
Primidone—GABRA1—central nervous system—multiple sclerosis	0.00157	0.00778	CbGeAlD
Primidone—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00156	0.00495	CcSEcCtD
Primidone—GABRA1—cerebellum—multiple sclerosis	0.00153	0.0076	CbGeAlD
Primidone—Psychotic disorder—Betamethasone—multiple sclerosis	0.00153	0.00485	CcSEcCtD
Primidone—Psychotic disorder—Dexamethasone—multiple sclerosis	0.00153	0.00485	CcSEcCtD
Primidone—Somnolence—Cladribine—multiple sclerosis	0.00152	0.00483	CcSEcCtD
Primidone—Decreased appetite—Cladribine—multiple sclerosis	0.00149	0.00472	CcSEcCtD
Primidone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00148	0.00469	CcSEcCtD
Primidone—Fatigue—Cladribine—multiple sclerosis	0.00147	0.00468	CcSEcCtD
Primidone—CHRNA7—brain—multiple sclerosis	0.00146	0.00723	CbGeAlD
Primidone—Arthralgia—Azathioprine—multiple sclerosis	0.00145	0.00461	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00144	0.00457	CcSEcCtD
Primidone—CHRNA4—brain—multiple sclerosis	0.00144	0.00714	CbGeAlD
Primidone—GABRG2—brain—multiple sclerosis	0.00141	0.00699	CbGeAlD
Primidone—GABRB2—brain—multiple sclerosis	0.00141	0.00699	CbGeAlD
Primidone—Skin disorder—Azathioprine—multiple sclerosis	0.00135	0.00429	CcSEcCtD
Primidone—Psychotic disorder—Prednisone—multiple sclerosis	0.00133	0.00423	CcSEcCtD
Primidone—GABRA2—brain—multiple sclerosis	0.00129	0.00639	CbGeAlD
Primidone—Anaemia—Mitoxantrone—multiple sclerosis	0.00127	0.00404	CcSEcCtD
Primidone—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00127	0.00402	CcSEcCtD
Primidone—Visual impairment—Prednisolone—multiple sclerosis	0.00125	0.00397	CcSEcCtD
Primidone—GABRA1—brain—multiple sclerosis	0.00124	0.00617	CbGeAlD
Primidone—Asthenia—Cladribine—multiple sclerosis	0.00123	0.0039	CcSEcCtD
Primidone—Visual disturbance—Methotrexate—multiple sclerosis	0.0012	0.00382	CcSEcCtD
Primidone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.0012	0.00381	CcSEcCtD
Primidone—Arthralgia—Mitoxantrone—multiple sclerosis	0.00117	0.00372	CcSEcCtD
Primidone—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00117	0.00372	CcSEcCtD
Primidone—Visual impairment—Methylprednisolone—multiple sclerosis	0.00115	0.00364	CcSEcCtD
Primidone—Dizziness—Cladribine—multiple sclerosis	0.00113	0.00359	CcSEcCtD
Primidone—Eye disorder—Methylprednisolone—multiple sclerosis	0.00111	0.00353	CcSEcCtD
Primidone—Skin disorder—Mitoxantrone—multiple sclerosis	0.00109	0.00347	CcSEcCtD
Primidone—Vomiting—Cladribine—multiple sclerosis	0.00109	0.00345	CcSEcCtD
Primidone—Rash—Cladribine—multiple sclerosis	0.00108	0.00342	CcSEcCtD
Primidone—Dermatitis—Cladribine—multiple sclerosis	0.00108	0.00342	CcSEcCtD
Primidone—Anorexia—Mitoxantrone—multiple sclerosis	0.00107	0.0034	CcSEcCtD
Primidone—Ataxia—Methotrexate—multiple sclerosis	0.00107	0.0034	CcSEcCtD
Primidone—Headache—Cladribine—multiple sclerosis	0.00107	0.0034	CcSEcCtD
Primidone—Depression—Prednisone—multiple sclerosis	0.00105	0.00333	CcSEcCtD
Primidone—Visual impairment—Betamethasone—multiple sclerosis	0.00104	0.00331	CcSEcCtD
Primidone—Visual impairment—Dexamethasone—multiple sclerosis	0.00104	0.00331	CcSEcCtD
Primidone—Mental disorder—Methylprednisolone—multiple sclerosis	0.00104	0.00331	CcSEcCtD
Primidone—Malnutrition—Methylprednisolone—multiple sclerosis	0.00104	0.00329	CcSEcCtD
Primidone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00102	0.00325	CcSEcCtD
Primidone—Nausea—Cladribine—multiple sclerosis	0.00102	0.00323	CcSEcCtD
Primidone—Vertigo—Prednisolone—multiple sclerosis	0.00101	0.00322	CcSEcCtD
Primidone—Eye disorder—Dexamethasone—multiple sclerosis	0.00101	0.00321	CcSEcCtD
Primidone—Eye disorder—Betamethasone—multiple sclerosis	0.00101	0.00321	CcSEcCtD
Primidone—Somnolence—Mitoxantrone—multiple sclerosis	0.000999	0.00317	CcSEcCtD
Primidone—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000977	0.0031	CcSEcCtD
Primidone—Fatigue—Mitoxantrone—multiple sclerosis	0.000969	0.00308	CcSEcCtD
Primidone—CYP2B6—nervous system—multiple sclerosis	0.00096	0.00476	CbGeAlD
Primidone—Vertigo—Triamcinolone—multiple sclerosis	0.000933	0.00296	CcSEcCtD
Primidone—Vertigo—Methylprednisolone—multiple sclerosis	0.000931	0.00296	CcSEcCtD
Primidone—Connective tissue disorder—Prednisone—multiple sclerosis	0.000926	0.00294	CcSEcCtD
Primidone—CYP2B6—central nervous system—multiple sclerosis	0.000924	0.00459	CbGeAlD
Primidone—Dizziness—Azathioprine—multiple sclerosis	0.000919	0.00292	CcSEcCtD
Primidone—Vomiting—Azathioprine—multiple sclerosis	0.000884	0.00281	CcSEcCtD
Primidone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000882	0.0028	CcSEcCtD
Primidone—Eye disorder—Prednisone—multiple sclerosis	0.000881	0.0028	CcSEcCtD
Primidone—Drowsiness—Methotrexate—multiple sclerosis	0.000878	0.00279	CcSEcCtD
Primidone—Rash—Azathioprine—multiple sclerosis	0.000876	0.00278	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000876	0.00278	CcSEcCtD
Primidone—Dermatitis—Azathioprine—multiple sclerosis	0.000875	0.00278	CcSEcCtD
Primidone—Depression—Methotrexate—multiple sclerosis	0.000875	0.00278	CcSEcCtD
Primidone—Headache—Azathioprine—multiple sclerosis	0.000871	0.00277	CcSEcCtD
Primidone—Vertigo—Dexamethasone—multiple sclerosis	0.000847	0.00269	CcSEcCtD
Primidone—Vertigo—Betamethasone—multiple sclerosis	0.000847	0.00269	CcSEcCtD
Primidone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000829	0.00263	CcSEcCtD
Primidone—Mental disorder—Prednisone—multiple sclerosis	0.000826	0.00262	CcSEcCtD
Primidone—Nausea—Azathioprine—multiple sclerosis	0.000825	0.00262	CcSEcCtD
Primidone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000821	0.00261	CcSEcCtD
Primidone—Malnutrition—Prednisone—multiple sclerosis	0.000821	0.00261	CcSEcCtD
Primidone—Agranulocytosis—Methotrexate—multiple sclerosis	0.000819	0.0026	CcSEcCtD
Primidone—CYP2C8—brain—multiple sclerosis	0.000818	0.00406	CbGeAlD
Primidone—Asthenia—Mitoxantrone—multiple sclerosis	0.000806	0.00256	CcSEcCtD
Primidone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000772	0.00245	CcSEcCtD
Primidone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000771	0.00245	CcSEcCtD
Primidone—Visual impairment—Methotrexate—multiple sclerosis	0.000759	0.00241	CcSEcCtD
Primidone—Anaemia—Prednisone—multiple sclerosis	0.000758	0.00241	CcSEcCtD
Primidone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000754	0.0024	CcSEcCtD
Primidone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000754	0.0024	CcSEcCtD
Primidone—Vertigo—Prednisone—multiple sclerosis	0.000737	0.00234	CcSEcCtD
Primidone—Eye disorder—Methotrexate—multiple sclerosis	0.000736	0.00234	CcSEcCtD
Primidone—CYP2B6—brain—multiple sclerosis	0.000734	0.00364	CbGeAlD
Primidone—Anorexia—Dexamethasone—multiple sclerosis	0.000733	0.00233	CcSEcCtD
Primidone—Anorexia—Betamethasone—multiple sclerosis	0.000733	0.00233	CcSEcCtD
Primidone—Fatigue—Triamcinolone—multiple sclerosis	0.000731	0.00232	CcSEcCtD
Primidone—Fatigue—Methylprednisolone—multiple sclerosis	0.000729	0.00232	CcSEcCtD
Primidone—CYP3A4—nervous system—multiple sclerosis	0.000725	0.0036	CbGeAlD
Primidone—Vomiting—Mitoxantrone—multiple sclerosis	0.000714	0.00227	CcSEcCtD
Primidone—Rash—Mitoxantrone—multiple sclerosis	0.000708	0.00225	CcSEcCtD
Primidone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000708	0.00225	CcSEcCtD
Primidone—Headache—Mitoxantrone—multiple sclerosis	0.000704	0.00224	CcSEcCtD
Primidone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000701	0.00223	CcSEcCtD
Primidone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000701	0.00223	CcSEcCtD
Primidone—Arthralgia—Prednisone—multiple sclerosis	0.000699	0.00222	CcSEcCtD
Primidone—CYP3A4—central nervous system—multiple sclerosis	0.000698	0.00346	CbGeAlD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000694	0.0022	CcSEcCtD
Primidone—Mental disorder—Methotrexate—multiple sclerosis	0.00069	0.00219	CcSEcCtD
Primidone—Malnutrition—Methotrexate—multiple sclerosis	0.000686	0.00218	CcSEcCtD
Primidone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000669	0.00212	CcSEcCtD
Primidone—Decreased appetite—Betamethasone—multiple sclerosis	0.000669	0.00212	CcSEcCtD
Primidone—Nausea—Mitoxantrone—multiple sclerosis	0.000667	0.00212	CcSEcCtD
Primidone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000664	0.00211	CcSEcCtD
Primidone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000664	0.00211	CcSEcCtD
Primidone—Fatigue—Dexamethasone—multiple sclerosis	0.000663	0.00211	CcSEcCtD
Primidone—Fatigue—Betamethasone—multiple sclerosis	0.000663	0.00211	CcSEcCtD
Primidone—Nervous system disorder—Prednisone—multiple sclerosis	0.000657	0.00209	CcSEcCtD
Primidone—Skin disorder—Prednisone—multiple sclerosis	0.000651	0.00207	CcSEcCtD
Primidone—Anorexia—Prednisone—multiple sclerosis	0.000638	0.00203	CcSEcCtD
Primidone—Anaemia—Methotrexate—multiple sclerosis	0.000634	0.00201	CcSEcCtD
Primidone—Vertigo—Methotrexate—multiple sclerosis	0.000616	0.00196	CcSEcCtD
Primidone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00061	0.00194	CcSEcCtD
Primidone—Dizziness—Prednisolone—multiple sclerosis	0.000609	0.00194	CcSEcCtD
Primidone—Asthenia—Triamcinolone—multiple sclerosis	0.000608	0.00193	CcSEcCtD
Primidone—Asthenia—Methylprednisolone—multiple sclerosis	0.000607	0.00193	CcSEcCtD
Primidone—Arthralgia—Methotrexate—multiple sclerosis	0.000584	0.00185	CcSEcCtD
Primidone—Decreased appetite—Prednisone—multiple sclerosis	0.000582	0.00185	CcSEcCtD
Primidone—Rash—Prednisolone—multiple sclerosis	0.000581	0.00185	CcSEcCtD
Primidone—Dermatitis—Prednisolone—multiple sclerosis	0.000581	0.00184	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00058	0.00184	CcSEcCtD
Primidone—Fatigue—Prednisone—multiple sclerosis	0.000577	0.00183	CcSEcCtD
Primidone—Headache—Prednisolone—multiple sclerosis	0.000577	0.00183	CcSEcCtD
Primidone—Dizziness—Triamcinolone—multiple sclerosis	0.00056	0.00178	CcSEcCtD
Primidone—Dizziness—Methylprednisolone—multiple sclerosis	0.000559	0.00178	CcSEcCtD
Primidone—Asthenia—Dexamethasone—multiple sclerosis	0.000552	0.00175	CcSEcCtD
Primidone—Asthenia—Betamethasone—multiple sclerosis	0.000552	0.00175	CcSEcCtD
Primidone—Nervous system disorder—Methotrexate—multiple sclerosis	0.000549	0.00174	CcSEcCtD
Primidone—Nausea—Prednisolone—multiple sclerosis	0.000547	0.00174	CcSEcCtD
Primidone—Skin disorder—Methotrexate—multiple sclerosis	0.000544	0.00173	CcSEcCtD
Primidone—Vomiting—Triamcinolone—multiple sclerosis	0.000539	0.00171	CcSEcCtD
Primidone—Vomiting—Methylprednisolone—multiple sclerosis	0.000538	0.00171	CcSEcCtD
Primidone—Rash—Triamcinolone—multiple sclerosis	0.000534	0.0017	CcSEcCtD
Primidone—Dermatitis—Triamcinolone—multiple sclerosis	0.000534	0.0017	CcSEcCtD
Primidone—Anorexia—Methotrexate—multiple sclerosis	0.000534	0.00169	CcSEcCtD
Primidone—Rash—Methylprednisolone—multiple sclerosis	0.000533	0.00169	CcSEcCtD
Primidone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000533	0.00169	CcSEcCtD
Primidone—Headache—Triamcinolone—multiple sclerosis	0.000531	0.00169	CcSEcCtD
Primidone—Headache—Methylprednisolone—multiple sclerosis	0.00053	0.00168	CcSEcCtD
Primidone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00051	0.00162	CcSEcCtD
Primidone—Dizziness—Betamethasone—multiple sclerosis	0.000509	0.00162	CcSEcCtD
Primidone—Dizziness—Dexamethasone—multiple sclerosis	0.000509	0.00162	CcSEcCtD
Primidone—Nausea—Triamcinolone—multiple sclerosis	0.000503	0.0016	CcSEcCtD
Primidone—Nausea—Methylprednisolone—multiple sclerosis	0.000502	0.0016	CcSEcCtD
Primidone—Somnolence—Methotrexate—multiple sclerosis	0.000498	0.00158	CcSEcCtD
Primidone—Vomiting—Betamethasone—multiple sclerosis	0.000489	0.00155	CcSEcCtD
Primidone—Vomiting—Dexamethasone—multiple sclerosis	0.000489	0.00155	CcSEcCtD
Primidone—Decreased appetite—Methotrexate—multiple sclerosis	0.000487	0.00155	CcSEcCtD
Primidone—Rash—Betamethasone—multiple sclerosis	0.000485	0.00154	CcSEcCtD
Primidone—Rash—Dexamethasone—multiple sclerosis	0.000485	0.00154	CcSEcCtD
Primidone—Dermatitis—Dexamethasone—multiple sclerosis	0.000484	0.00154	CcSEcCtD
Primidone—Dermatitis—Betamethasone—multiple sclerosis	0.000484	0.00154	CcSEcCtD
Primidone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000483	0.00154	CcSEcCtD
Primidone—Fatigue—Methotrexate—multiple sclerosis	0.000483	0.00153	CcSEcCtD
Primidone—Headache—Betamethasone—multiple sclerosis	0.000482	0.00153	CcSEcCtD
Primidone—Headache—Dexamethasone—multiple sclerosis	0.000482	0.00153	CcSEcCtD
Primidone—Asthenia—Prednisone—multiple sclerosis	0.000481	0.00153	CcSEcCtD
Primidone—Nausea—Dexamethasone—multiple sclerosis	0.000457	0.00145	CcSEcCtD
Primidone—Nausea—Betamethasone—multiple sclerosis	0.000457	0.00145	CcSEcCtD
Primidone—Dizziness—Prednisone—multiple sclerosis	0.000443	0.00141	CcSEcCtD
Primidone—Vomiting—Prednisone—multiple sclerosis	0.000426	0.00135	CcSEcCtD
Primidone—Rash—Prednisone—multiple sclerosis	0.000422	0.00134	CcSEcCtD
Primidone—Dermatitis—Prednisone—multiple sclerosis	0.000422	0.00134	CcSEcCtD
Primidone—Headache—Prednisone—multiple sclerosis	0.00042	0.00133	CcSEcCtD
Primidone—Asthenia—Methotrexate—multiple sclerosis	0.000402	0.00128	CcSEcCtD
Primidone—Nausea—Prednisone—multiple sclerosis	0.000398	0.00126	CcSEcCtD
Primidone—Dizziness—Methotrexate—multiple sclerosis	0.00037	0.00118	CcSEcCtD
Primidone—Vomiting—Methotrexate—multiple sclerosis	0.000356	0.00113	CcSEcCtD
Primidone—Rash—Methotrexate—multiple sclerosis	0.000353	0.00112	CcSEcCtD
Primidone—Dermatitis—Methotrexate—multiple sclerosis	0.000353	0.00112	CcSEcCtD
Primidone—Headache—Methotrexate—multiple sclerosis	0.000351	0.00111	CcSEcCtD
Primidone—Nausea—Methotrexate—multiple sclerosis	0.000332	0.00106	CcSEcCtD
Primidone—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000241	0.00411	CbGpPWpGaD
Primidone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000233	0.00396	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—BCHE—multiple sclerosis	0.000233	0.00396	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000232	0.00395	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—BDNF—multiple sclerosis	0.000231	0.00394	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000225	0.00383	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—BCHE—multiple sclerosis	0.000212	0.0036	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.00021	0.00358	CbGpPWpGaD
Primidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00021	0.00358	CbGpPWpGaD
Primidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00021	0.00358	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000208	0.00354	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000208	0.00354	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—SPP1—multiple sclerosis	0.000205	0.0035	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000205	0.00349	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000205	0.00349	CbGpPWpGaD
Primidone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000203	0.00345	CbGpPWpGaD
Primidone—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000202	0.00344	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000201	0.00342	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000197	0.00335	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000194	0.00331	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000193	0.00329	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000191	0.00325	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000186	0.00316	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000186	0.00316	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000183	0.00312	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000183	0.00312	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000181	0.00308	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—BCHE—multiple sclerosis	0.000178	0.00303	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000177	0.00302	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000174	0.00297	CbGpPWpGaD
Primidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000173	0.00295	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—BCHE—multiple sclerosis	0.000172	0.00294	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000172	0.00294	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000169	0.00288	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000169	0.00288	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000169	0.00288	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000169	0.00288	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000167	0.00284	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000167	0.00284	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000166	0.00283	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000166	0.00283	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000163	0.00278	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000162	0.00276	CbGpPWpGaD
Primidone—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.00016	0.00272	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000159	0.00272	CbGpPWpGaD
Primidone—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000157	0.00268	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000149	0.00254	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—BCHE—multiple sclerosis	0.000148	0.00252	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000147	0.0025	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—BCHE—multiple sclerosis	0.000146	0.00249	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000145	0.00246	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000145	0.00246	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000143	0.00243	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000143	0.00243	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000142	0.00242	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000139	0.00237	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000135	0.00229	CbGpPWpGaD
Primidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000134	0.00228	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—BCHE—multiple sclerosis	0.000134	0.00228	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000131	0.00223	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.00013	0.00222	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—BCHE—multiple sclerosis	0.00013	0.00221	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000129	0.0022	CbGpPWpGaD
Primidone—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000128	0.00219	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000128	0.00219	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—BCHE—multiple sclerosis	0.000127	0.00217	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000126	0.00215	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—BCHE—multiple sclerosis	0.000125	0.00213	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000124	0.00212	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000123	0.0021	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—BCHE—multiple sclerosis	0.000122	0.00208	CbGpPWpGaD
Primidone—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000118	0.00201	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000118	0.00201	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000116	0.00198	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000112	0.0019	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000112	0.0019	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00011	0.00188	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00011	0.00188	CbGpPWpGaD
Primidone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000109	0.00185	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000108	0.00183	CbGpPWpGaD
Primidone—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000107	0.00183	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—BCHE—multiple sclerosis	0.000107	0.00182	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000106	0.00181	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000105	0.00179	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000104	0.00177	CbGpPWpGaD
Primidone—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000104	0.00177	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000103	0.00176	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000103	0.00175	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000101	0.00173	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.97e-05	0.0017	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.72e-05	0.00166	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—STAT3—multiple sclerosis	9.71e-05	0.00165	CbGpPWpGaD
Primidone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.7e-05	0.00165	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.4e-05	0.0016	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—TNF—multiple sclerosis	9.38e-05	0.0016	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.13e-05	0.00156	CbGpPWpGaD
Primidone—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.02e-05	0.00154	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.97e-05	0.00153	CbGpPWpGaD
Primidone—GRIK2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.87e-05	0.00151	CbGpPWpGaD
Primidone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.84e-05	0.00151	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—MAPK1—multiple sclerosis	8.82e-05	0.0015	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.81e-05	0.0015	CbGpPWpGaD
Primidone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.81e-05	0.0015	CbGpPWpGaD
Primidone—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	8.75e-05	0.00149	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.6e-05	0.00146	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.5e-05	0.00145	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.07e-05	0.00137	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.99e-05	0.00136	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.99e-05	0.00136	CbGpPWpGaD
Primidone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.86e-05	0.00134	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7.78e-05	0.00132	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	7.64e-05	0.0013	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.57e-05	0.00129	CbGpPWpGaD
Primidone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.56e-05	0.00129	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.51e-05	0.00128	CbGpPWpGaD
Primidone—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.51e-05	0.00128	CbGpPWpGaD
Primidone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.41e-05	0.00126	CbGpPWpGaD
Primidone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.17e-05	0.00122	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.13e-05	0.00121	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.13e-05	0.00121	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.94e-05	0.00118	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.91e-05	0.00118	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—MAPK1—multiple sclerosis	6.8e-05	0.00116	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	6.78e-05	0.00116	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.78e-05	0.00115	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.58e-05	0.00112	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	6.58e-05	0.00112	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.52e-05	0.00111	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.5e-05	0.00111	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.5e-05	0.00111	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.47e-05	0.0011	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.35e-05	0.00108	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.2e-05	0.00106	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—MAPK1—multiple sclerosis	6.18e-05	0.00105	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.17e-05	0.00105	CbGpPWpGaD
Primidone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.13e-05	0.00104	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SRM—multiple sclerosis	5.96e-05	0.00102	CbGpPWpGaD
Primidone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.83e-05	0.000993	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.64e-05	0.000961	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.57e-05	0.000949	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.55e-05	0.000946	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.55e-05	0.000946	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—POMC—multiple sclerosis	5.53e-05	0.000941	CbGpPWpGaD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.42e-05	0.000923	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.4e-05	0.00092	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.39e-05	0.000918	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.29e-05	0.0009	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—MAPK1—multiple sclerosis	5.2e-05	0.000885	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.1e-05	0.000868	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SRM—multiple sclerosis	5.05e-05	0.00086	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—MAPK1—multiple sclerosis	5.04e-05	0.000859	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.03e-05	0.000857	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.03e-05	0.000857	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.95e-05	0.000843	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.86e-05	0.000828	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.78e-05	0.000814	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.73e-05	0.000806	CbGpPWpGaD
Primidone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.73e-05	0.000805	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.68e-05	0.000797	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.66e-05	0.000794	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SRM—multiple sclerosis	4.51e-05	0.000768	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—MAPK1—multiple sclerosis	4.32e-05	0.000736	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—MAPK1—multiple sclerosis	4.27e-05	0.000727	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	4.2e-05	0.000716	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	4.2e-05	0.000716	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.18e-05	0.000711	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SRM—multiple sclerosis	4.11e-05	0.0007	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.07e-05	0.000694	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—MAPK1—multiple sclerosis	3.9e-05	0.000665	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.84e-05	0.000655	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.82e-05	0.00065	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.81e-05	0.000649	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—MAPK1—multiple sclerosis	3.79e-05	0.000646	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.75e-05	0.000638	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—MAPK1—multiple sclerosis	3.72e-05	0.000634	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.7e-05	0.00063	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—MAPK1—multiple sclerosis	3.66e-05	0.000623	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—MAPK1—multiple sclerosis	3.57e-05	0.000608	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.56e-05	0.000606	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.56e-05	0.000606	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SRM—multiple sclerosis	3.51e-05	0.000598	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.48e-05	0.000592	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.38e-05	0.000576	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.29e-05	0.00056	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.25e-05	0.000554	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.25e-05	0.000554	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.23e-05	0.00055	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.18e-05	0.000542	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.17e-05	0.000541	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.17e-05	0.000541	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.17e-05	0.00054	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—MAPK1—multiple sclerosis	3.12e-05	0.000532	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.1e-05	0.000529	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.1e-05	0.000527	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.9e-05	0.000495	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.89e-05	0.000493	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.89e-05	0.000493	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.83e-05	0.000482	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SRM—multiple sclerosis	2.71e-05	0.000462	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.71e-05	0.000461	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.7e-05	0.000459	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.65e-05	0.000451	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.51e-05	0.000428	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.47e-05	0.000421	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.47e-05	0.000421	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.42e-05	0.000412	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.41e-05	0.00041	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.26e-05	0.000385	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.19e-05	0.000374	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.09e-05	0.000356	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.91e-05	0.000325	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.91e-05	0.000325	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.87e-05	0.000319	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.87e-05	0.000318	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.83e-05	0.000311	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.8e-05	0.000306	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.75e-05	0.000297	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.7e-05	0.00029	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.64e-05	0.000279	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.6e-05	0.000273	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000264	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.46e-05	0.000249	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.46e-05	0.000249	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.45e-05	0.000248	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.45e-05	0.000246	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.38e-05	0.000235	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.33e-05	0.000227	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000215	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.25e-05	0.000213	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.14e-05	0.000194	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—APOE—multiple sclerosis	1.1e-05	0.000187	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.08e-05	0.000183	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—POMC—multiple sclerosis	9.45e-06	0.000161	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—APOE—multiple sclerosis	9.31e-06	0.000159	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ALB—multiple sclerosis	8.62e-06	0.000147	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—APOE—multiple sclerosis	8.31e-06	0.000142	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.31e-06	0.000142	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—POMC—multiple sclerosis	8e-06	0.000136	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—APOE—multiple sclerosis	7.58e-06	0.000129	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ALB—multiple sclerosis	7.29e-06	0.000124	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—POMC—multiple sclerosis	7.14e-06	0.000122	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—POMC—multiple sclerosis	6.51e-06	0.000111	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ALB—multiple sclerosis	6.51e-06	0.000111	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—APOE—multiple sclerosis	6.48e-06	0.00011	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ALB—multiple sclerosis	5.94e-06	0.000101	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—POMC—multiple sclerosis	5.56e-06	9.48e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ALB—multiple sclerosis	5.07e-06	8.64e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—APOE—multiple sclerosis	5e-06	8.52e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—POMC—multiple sclerosis	4.29e-06	7.32e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.92e-06	6.67e-05	CbGpPWpGaD
